Clinical Trial Update: A Study of ZT002 in Healthy Participants [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety and tolerability of ZT002 in healthy participants and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ZT002

Snippet

Sponsor: QL Biopharmaceutical Australia Pty Ltd | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED